Live Quote · NASDAQGYREHealthcare· Biotechnology

Gyre Therapeutics, Inc.

$4.21▼ 6.86%($-0.31)
MKT CAP $460.79MNEXT EARNINGS Mar 11, 2027
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
65
Valuation
40
Profitability
45
Growth
68
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GYRE research report →

Analyst Price Target
$17.00+303.8% vs. today

Range $16 – $18

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-43.79% · this period
$8.76$6.38$4.01Nov 20May 26Nov 20
52-Week Range5% of range
Low
$3.97
Current
$4.21
High
$9.14